Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identifying and Overcoming Challenges in Developing Effective Treatments for Usher 1B: A Workshop Report.

Translational vision science & technology - 1 Feb 2023

Boye Shannon E, Durham Todd, Laster Amy, Gelfman Claire M, Sahel José-Alain

Abstract excerpt

Purpose: To identify challenges and opportunities for the development of treatments for Usher syndrome (USH) type 1B. Methods: In September 2021, the Foundation Fighting Blindness hosted a virtual workshop of clinicians, academic and industry researchers, advocates, and affected individuals and their families to discuss the challenges and opportunities for USH1B treatment development. Results: The workshop began...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Mice
Share to Mutation
Share to Myosin VIIa

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Myosins

Share to Usher Syndromes

Source

Open in PubMed Open full text

Identifiers

PMID: 36723965
DOI: 10.1167/tvst.12.2.2
PMCID: PMC9904327

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identifying and Overcoming Challenges in Developing Effective Treatments for Usher 1B: A Workshop Report.PMID 36723965Read ↗

Pathogenesis and Treatment of Usher Syndrome Type IIA.Semantic proximity Read ↗

A Genomic Analysis of Usher Syndrome: Population-Scale Prevalence and Therapeutic Targets.Semantic proximity Read ↗

A Genomic Analysis of Usher Syndrome: Population-Scale Prevalence and Therapeutic TargetsSemantic proximity Read ↗

Expression of two major isoforms of MYO7A in the retina: Considerations for gene therapy of Usher syndrome type 1B.Semantic proximity Read ↗

USH2A-retinopathy: From genetics to therapeutics.Semantic proximity Read ↗

Disease mechanisms and gene therapy for Usher syndrome.Semantic proximity Read ↗

Is it Usher syndrome? Collaborative diagnosis and molecular genetics of patients with visual impairment and hearing loss.Semantic proximity Read ↗

Novel biallelic USH2A variants in a patient with usher syndrome type IIA- a case report.Semantic proximity Read ↗

[Advances on gene therapy for USH2A exon 13 related inherited retinal dystrophy].Semantic proximity Read ↗

Gene Therapy for the Retinal Degeneration of Usher Syndrome Caused by Mutations in MYO7A.Semantic proximity Read ↗

Expanding the options for therapeutic exon skipping as a future treatment for <i>USH2A</i> -associated disease by 3D structural modeling of newly formed hybrid domainsSemantic proximity Read ↗

CDH23-Associated Usher Syndrome: Clinical Features, Retinal Imaging, and Natural History.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.